ストックスクリーナーアプリを入手
30.94
7.92%
2.27
プレマーケット:
31.94
1.00
+3.23%
前日終値:
$28.67
開ける：
$28.64
24時間の取引高:
1.27M
Relative Volume:
1.60
時価総額：
$2.36B
収益：
-
当期純損益:
$-64.16M
株価収益率:
-24.36
EPS:
-1.2702
ネットキャッシュフロー:
$-69.06M
1週間 パフォーマンス:
+15.82%
1か月 パフォーマンス:
+18.59%
6か月 パフォーマンス:
+24.76%
1年 パフォーマンス:
-15.21%
1日の値動き範囲:
$28.32
$31.95
1週間の範囲:
$26.22
$31.95
52週間の値動き範囲:
$14.80
$40.47
Cg Oncology Inc Stock (CGON) Company Profile
CGON を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
30.94 | 2.09B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-19 | 開始されました | Piper Sandler | Overweight |
| 2025-07-10 | 再開されました | Goldman | Buy |
| 2025-05-02 | 開始されました | JP Morgan | Overweight |
| 2025-04-16 | 開始されました | Scotiabank | Sector Perform |
| 2025-01-07 | 開始されました | TD Cowen | Buy |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-09-23 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-08-28 | 開始されました | ROTH MKM | Buy |
| 2024-06-28 | 開始されました | BofA Securities | Buy |
| 2024-02-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-02-20 | 開始されました | Goldman | Neutral |
| 2024-02-20 | 開始されました | Morgan Stanley | Overweight |
| 2024-02-14 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Cg Oncology Inc (CGON) 最新ニュース
Song Hong Fang, CG Oncology director, sells $2.78m in shares - Investing.com Australia
Can CG Oncology Inc. withstand a market correctionJuly 2025 Rallies & Fast Moving Stock Trade Plans - khodrobank.com
Visualizing CG Oncology Inc. stock with heatmapsPortfolio Gains Report & Real-Time Volume Spike Alerts - Newser
Chart based exit strategy for CG Oncology Inc.Weekly Loss Report & Verified Momentum Watchlists - Newser
Detecting support and resistance levels for CG Oncology Inc.July 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - Newser
CG Oncology Directors Sell Shares, Buy Others Amid Market Volatility. - AInvest
How does CG Oncology Inc. score in quality rankingsWeekly Risk Report & AI Powered Buy/Sell Recommendations - khodrobank.com
Understanding CG Oncology Inc.’s price movementM&A Rumor & Low Volatility Stock Suggestions - Newser
Can CG Oncology Inc. deliver alphaJuly 2025 Levels & Capital Protection Trading Alerts - khodrobank.com
What moving averages say about CG Oncology Inc.July 2025 Final Week & Free Expert Approved Momentum Trade Ideas - Newser
Will CG Oncology Inc. stock go up soonShort Setup & Real-Time Volume Triggers - Newser
Real time breakdown of CG Oncology Inc. stock performance - Newser
CG Oncology Inc. stock chart pattern explained2025 Biggest Moves & Long-Term Investment Growth Plans - Newser
Ani Pharmaceuticals shares rise 1.98% after-hours following CG Oncology's PIVOT-006 study enrollment completion. - AInvest
Will CG Oncology Inc. benefit from macro trendsSwing Trade & Accurate Intraday Trading Signals - Newser
CG Oncology Completes Enrollment for Phase 3 Study - Orange County Business Journal
CG Oncology completes enrollment for bladder cancer therapy trial - Investing.com
CG Oncology completes enrollment in PIVOT-006 - TipRanks
CG Oncology Completes Rapid Enrollment in Phase 3 Study for Intermediate-Risk Non-Muscle Invasive Bladder Cancer - Quiver Quantitative
CG Oncology Completes Enrollment in PIVOT-006 Trial for Intermediate-Risk Non-Muscle Invasive Bladder Cancer - AInvest
Largest-Ever Trial: 360 Patients Join CG Oncology's Breakthrough Bladder Cancer Study One Year Early - Stock Titan
Using economic indicators to assess CG Oncology Inc. potentialMarket Activity Recap & Entry Point Confirmation Signals - Newser
Real time alert setup for CG Oncology Inc. performanceJuly 2025 Momentum & Daily Profit Focused Screening - Newser
Developing predictive dashboards with CG Oncology Inc. data2025 Retail Activity & Real-Time Volume Triggers - Newser
What are CG Oncology Inc.’s technical support levels2025 Volatility Report & Risk Managed Trade Strategies - khodrobank.com
How to build a custom watchlist for CG Oncology Inc.Market Movement Recap & Community Supported Trade Ideas - Newser
Analyzing CG Oncology Inc. with risk reward ratio chartsTrade Performance Summary & AI Powered Buy/Sell Recommendations - Newser
Will CG Oncology Inc. outperform the marketWall Street Watch & Intraday High Probability Alerts - Newser
Should you hold or exit CG Oncology Inc. nowEntry Point & Free Verified High Yield Trade Plans - Newser
Published on: 2025-09-03 00:18:12 - Newser
Can CG Oncology Inc. sustain earnings growthWeekly Earnings Recap & Long-Term Safe Investment Plans - khodrobank.com
Is CG Oncology Inc. stock reversal real or fakeBear Alert & Low Risk High Reward Trade Ideas - Newser
Technical signs of recovery in CG Oncology Inc.Quarterly Portfolio Review & Free Low Drawdown Momentum Trade Ideas - Newser
Using flow based indicators on CG Oncology Inc.2025 Price Momentum & Consistent Growth Stock Picks - Newser
Is CG Oncology Inc. still worth holding after the dipQuarterly Performance Summary & Verified Chart Pattern Trade Signals - Newser
Is CG Oncology Inc. a candidate for recovery playJuly 2025 Sector Moves & Low Volatility Stock Recommendations - Newser
CG Oncology Inc. stock trend forecastForecast Cut & AI Driven Stock Movement Reports - Newser
Can CG Oncology Inc. hit a new high this monthTrade Entry Summary & Low Risk Entry Point Tips - Newser
Chart based analysis of CG Oncology Inc. trendsJuly 2025 Momentum & Risk Managed Investment Entry Signals - Newser
What is the target price for CG Oncology Inc. stockJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - khodrobank.com
Risk adjusted return profile for CG Oncology Inc. analyzedWeekly Loss Report & Reliable Entry Point Trade Alerts - Newser
Non Muscle Invasive Bladder Cancer Pipeline Insight Report 2025: Emerging Therapies and Treatment Advances - AInvest
How CG Oncology Inc. stock performs during market volatilityDividend Hike & AI Forecast for Swing Trade Picks - Newser
How cyclical is CG Oncology Inc.’s revenue streamQuarterly Trade Review & Reliable Breakout Stock Forecasts - khodrobank.com
Cg Oncology Inc (CGON) 財務データ
収益
当期純利益
現金流量
EPS
1.75%
1.11%
大文字化:
|
ボリューム (24 時間):